[go: up one dir, main page]

ES2189163T3 - Nitro-benzamidas utiles como agentes anti-arritmicos. - Google Patents

Nitro-benzamidas utiles como agentes anti-arritmicos.

Info

Publication number
ES2189163T3
ES2189163T3 ES98920498T ES98920498T ES2189163T3 ES 2189163 T3 ES2189163 T3 ES 2189163T3 ES 98920498 T ES98920498 T ES 98920498T ES 98920498 T ES98920498 T ES 98920498T ES 2189163 T3 ES2189163 T3 ES 2189163T3
Authority
ES
Spain
Prior art keywords
provides
nitro
benzamidas
arritmic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98920498T
Other languages
English (en)
Inventor
Graham Ralph Smithkline Slater
Paul Jeffrey Smithkline Westlake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2189163T3 publication Critical patent/ES2189163T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Hidrocloruro hidratado de N-{[}3-{[}{[}2-{(}3,4- dimetoxifenil{etil]amino{]}propil{]}-4-nitro benzamida que se caracteriza porque: (i) comprende agua en el intervalo entre 1,7 a 2,4equivalentes molares; y/o (ii) tiene un punto de fusión por encima de 145ºC y/o (iii) proporciona un espectro infrarrojo que contiene picos a 3510, 3342, 3076, 1665, 1598, 1343, 1330, 1216 y 801 cm{sup,-1}; y/o (iv) proporciona un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos tal y como se representa en la Tabla I; y/o (v) proporciona una configuración de refracción de polvo de rayos X (XRPD) tal y como se representa en la Tabla II; un procedimiento de preparación de dicho compuesto, una composición farmacéutica que lo comprende y la utilización de dicho compuesto en medicina.
ES98920498T 1997-03-27 1998-03-24 Nitro-benzamidas utiles como agentes anti-arritmicos. Expired - Lifetime ES2189163T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706376.2A GB9706376D0 (en) 1997-03-27 1997-03-27 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ES2189163T3 true ES2189163T3 (es) 2003-07-01

Family

ID=10809958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98920498T Expired - Lifetime ES2189163T3 (es) 1997-03-27 1998-03-24 Nitro-benzamidas utiles como agentes anti-arritmicos.

Country Status (37)

Country Link
US (1) US20040092771A1 (es)
EP (1) EP0971882B1 (es)
JP (1) JP2001518088A (es)
KR (1) KR20010005566A (es)
CN (1) CN1257478A (es)
AP (1) AP1205A (es)
AT (1) ATE228997T1 (es)
AU (1) AU741476B2 (es)
BG (1) BG103829A (es)
BR (1) BR9809054A (es)
CA (1) CA2285197A1 (es)
DE (1) DE69809891T2 (es)
DK (1) DK0971882T3 (es)
DZ (1) DZ2452A1 (es)
EA (1) EA002439B1 (es)
EG (1) EG21226A (es)
ES (1) ES2189163T3 (es)
GB (1) GB9706376D0 (es)
HK (1) HK1025089A1 (es)
HU (1) HUP0001683A3 (es)
ID (1) ID22787A (es)
IL (1) IL132042A0 (es)
IN (1) IN188180B (es)
MA (1) MA26477A1 (es)
NO (1) NO994682L (es)
NZ (1) NZ337794A (es)
OA (1) OA11200A (es)
PE (1) PE61799A1 (es)
PL (1) PL335879A1 (es)
PT (1) PT971882E (es)
SK (1) SK283056B6 (es)
TR (1) TR199902356T2 (es)
TW (1) TW518318B (es)
UA (1) UA57066C2 (es)
UY (1) UY24937A1 (es)
WO (1) WO1998043947A1 (es)
ZA (1) ZA982558B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923934D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Plc Novel pharmaceutical
GB9923933D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Lab Novel pharmaceutical
US8483008B2 (en) * 2008-11-08 2013-07-09 Westerngeco L.L.C. Coil shooting mode

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer

Also Published As

Publication number Publication date
NO994682D0 (no) 1999-09-24
SK283056B6 (sk) 2003-02-04
TW518318B (en) 2003-01-21
NO994682L (no) 1999-09-24
IN188180B (es) 2002-08-31
UA57066C2 (uk) 2003-06-16
CN1257478A (zh) 2000-06-21
UY24937A1 (es) 2000-12-29
BR9809054A (pt) 2000-08-01
BG103829A (bg) 2000-04-28
EA199900879A1 (ru) 2000-04-24
DZ2452A1 (fr) 2003-01-18
PT971882E (pt) 2003-04-30
HUP0001683A2 (hu) 2000-09-28
JP2001518088A (ja) 2001-10-09
HUP0001683A3 (en) 2002-11-28
AU741476B2 (en) 2001-11-29
EP0971882B1 (en) 2002-12-04
ZA982558B (en) 1999-09-27
PE61799A1 (es) 1999-09-10
EA002439B1 (ru) 2002-04-25
NZ337794A (en) 2001-06-29
IL132042A0 (en) 2001-03-19
AP9901651A0 (en) 1999-09-30
OA11200A (en) 2003-05-21
US20040092771A1 (en) 2004-05-13
AP1205A (en) 2003-09-17
DE69809891D1 (de) 2003-01-16
HK1025089A1 (en) 2000-11-03
EP0971882A1 (en) 2000-01-19
PL335879A1 (en) 2000-05-22
DK0971882T3 (da) 2003-03-31
TR199902356T2 (xx) 2000-01-21
DE69809891T2 (de) 2003-07-24
MA26477A1 (fr) 2004-12-20
GB9706376D0 (en) 1997-05-14
ID22787A (id) 1999-12-09
KR20010005566A (ko) 2001-01-15
EG21226A (en) 2001-03-31
CA2285197A1 (en) 1998-10-08
AU7334198A (en) 1998-10-22
WO1998043947A1 (en) 1998-10-08
ATE228997T1 (de) 2002-12-15
SK130299A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
EA200200571A1 (ru) Новая композиция и ее применение
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
SE8700499D0 (sv) Novel pharmacologically active compounds
IS6614A (is) Ný tríasólpýrimídínefnasambönd
ES539076A0 (es) Procedimiento para preparar piridin-2-eteres o piridin-2-tioeteres
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
PT1109812E (pt) Pirrolobenzodiazepinas
DK537389D0 (da) Glycosidase-inhibitoren salbostatin, dens fremstilling og anvendelse
ES2056692T3 (es) Triacinas y pirimidinas trisustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
ITMI910778A0 (it) Procedimento per la produzione di urea ad elevata efficienza energetica
ES2189163T3 (es) Nitro-benzamidas utiles como agentes anti-arritmicos.
BG106233A (en) Indole derivatives
ITMI20000572A0 (it) Serratura per serramenti ad elevata flessibilita' di impiego
AR044175A1 (es) Compuestos de cefemo
IT1303793B1 (it) "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
GB2246778B (en) Improvements in or relating to propylamine derivatives
DK158729C (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat
IT1302022B1 (it) Metodo per eseguire schermografie di parti del corpo di un pazientecon tecnica slot liberamente programmabili e dispositivo per la
DE2960627D1 (en) 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation
BRPI0407304A (pt) Agentes antibacterianos
DE2961713D1 (en) Organic diamine compounds for use as oral hypoglycemic agents and pharmaceutical compositions thereof
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist
ZA908298B (en) Optically active thiazetoquinoline-3-carboxylic acid compound,method for preparation thereof,and a pharmaceutical composition comprising the same